News Releases: Cornea

  • February 4, 2021 | Emory Eye Center is part of a 10-year nationwide study that examines children after cataract removal. Emory Eye Center glaucoma specialists participated in a multi-center, 10-year follow-up clinical trial called the NEI funded Infant Aphakia Treatment Study (IATS). The study findings discovered that children who had undergone cataract surgery as an infant may have an increased risk of glaucoma-related vision damage later in life.

  • March is Cataract Awareness Month: Get Answers to 5 Common Cataract Questions
    Mar. 13, 2017 | (ATLANTA) The lens of the eye works like a camera to focus light images on the retina at the back of the eye. Those images are sent to the brain, which allows you to know what you’re seeing. When the lens becomes cloudy and rigid, it can keep images from reaching the retina and decrease your vision. This clouding of the natural lens is called a cataract.

  • Emory Vision improves patient experiences with the newest LASIK technology
    Jan. 4, 2017 | (ATLANTA) Emory Vision, the LASIK service of Emory Eye Center, now offers the very latest equipment available to make LASIK procedures even more comfortable and convenient for patients.

  • Emory Eye Center offers femtosecond cataract surgery Bladeless LenSx ® system allows for maximum precision

    Dec. 18, 2015 | (ATLANTA) Emory Eye Center now offers femtosecond laser technology for those patients undergoing cataract surgery. The system can replace blade use during surgery with a femtosecond laser, providing a no-stitch procedure and can increase surgical precision and maximize surgery customization.  This allows for improvements in how we get appropriate patients to have less dependence on glasses or contacts after cataract surgery.

  • Emory Eye Center opens new clinic in Johns Creek-Cumming area
    Nov. 14, 2013 | (ATLANTA) Emory Eye Center has opened a new clinic in the Johns Creek/Cumming area. Comprehensive ophthalmologist Vandana C. Reddy will see patients at the Emory at Cumming Family Practice complex on Peachtree Parkway several days each week.

  • Emory Eye Center Physician Has New Book on Corneal Collagen Cross-Linking
    April 30, 2013 | (ATLANTA) Emory Eye Center cornea specialist J. Bradley Randleman has co-authored the book, Corneal Collagen Cross-Linking (Slack, 2013) along with physician/researcher Farhad Hafezi of the University of Geneva, Switzerland and Doheny Eye Institute, Los Angeles. The comprehensive text brings together cross-linking theory, treatment, outcomes, complications and their management.

  • Emory Eye Center Recipient of Knights Templar Award
    February 27, 2013 | (ATLANTA) The Emory Eye Center was recently awarded $32,000 by the Georgia Knights Templar Educational Foundation, Inc. The funding will be used to continue important educational and research opportunities that impact the entire state of Georgia. Over the past several years, the Georgia Knights Templar has awarded $750,000 to the Emory Eye Center.

  • New device for end-stage macular degeneration that may help some see better
    Jan. 2, 2013 | (ATLANTA) Emory Eye Center is the first center in Georgia to offer a new technology proven to help the vision of some patients with end-stage age-related macular degeneration (AMD).

  • Emory Eye Center offers new technology for some patients with chronic dry eye
    Dec. 13, 2012 | (ATLANTA) Emory Eye Center is the first academic center in Georgia to offer a new technology that can help patients who suffer from a certain type of dry eye syndrome (DES). The technology, LipiFlow: Thermal Pulsation ™ is a novel way to treat evaporative dry eye disease caused by Meibomian gland dysfunction (MGD). Opening and clearing the blocked oil glands allows the body to resume the natural production of lipids which are needed for a healthy tear film.

  • Three Emory Eye Center physicians honored in "135 Leading Ophthalmologists
    in America" listing

    August 25, 2011 | (ATLANTA) Maria M. Aaron, MD, Timothy W. Olsen, MD and J. Bradley Randleman, MD were elected to Becker's Ambulatory Surgery Centers (ASC) Review's "135 Leading Ophthalmologists in America" list. Honorees are selected based on the awards they have received from major organizations in the field, leadership in those organizations, work on professional publications and their positions of service. 

  • Emory Eye Center Physician Recipient of the Kritzinger Memorial Award
    July 21, 2011 | (ATLANTA) Emory Eye Center ophthalmologist J. Bradley Randleman, MD, is the recipient of the Kritzinger Memorial Award, given by the International Society of Refractive Surgery of the American Academy of Ophthalmology.

  • J. Bradley Randleman, MD, Named Editor in Chief of the Journal of Refractive Surgery
    Feb. 7, 2011 | (ATLANTA) Emory Eye Center ophthalmologist J. Bradley Randleman, MD, has been named editor in chief of the Journal of Refractive Surgery. The journal is the official publication of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology. The journal is a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures.

  • Emory Eye Center Researcher Edelhauser to Present Charles D. Kelman Innovator’s Lecture at American Society of Cataract and Refractive Surgeons
    April 2, 2010 | (ATLANTA) Emory Eye Center research professor Henry F. Edelhauser, PhD, has been named the Charles D. Kelman Innovator’s Lecturer for the national meeting of the American Society of Cataract and Refractive Surgeons (ASCRS) meeting in April. The ASCRS lectureship honors the work of individuals whose creativity has benefited ophthalmologists and their patients. The lecture is presented during a special session at the annual ASCRS Symposium on Cataract, IOL and Refractive Surgery. Charles D. Kelman, MD, presented the first lecture in 1985. In recognition of the ongoing contribution of the late Dr. Kelman to anterior segment surgery—the invention of phacoemulsification—the lecture was renamed for him in 2003. Dr. Edelhauser’s title is “Evolution of Surgical Pharmacology: Reviewing the Past and Looking to the Future.”

  • Emory Eye Center Faculty Member Wins First Binkhorst Young Ophthalmologist Award
    March 29, 2010 | (ATLANTA) J. Bradley Randleman, MD, associate professor in the section of Cornea, External Disease, and Refractive Surgery at Emory Eye Center, has been chosen the first winner of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation’s Binkhorst Young Ophthalmologist Award. The award provides the means for an outstanding young ophthalmologist to travel to the ASCRS Annual Meeting and present a paper in memory of ophthalmologist Cornelius Binkhorst, MD.

  • Emory Eye Center Professor R. Doyle Stulting Named Hughes Professor
    (ATLANTA) R. Doyle Stulting, MD, PhD, professor of Ophthalmology and director of the Cornea Service, Emory Eye Center, was appointed the John H. and Helen S. Hughes Professor in Ophthalmology, effective August 1, 2009. Stulting is considered a leading authority in the areas of corneal and external disease. He is the President-elect of the leading society in his subspecialty, the American Society of Cataract and Refractive Surgeons (ASCRS).

  • Emory Eye Center Neuro-Ophthalmologists Collaborate to Write Neuro-Ophthalmology Illustrated
    September 3, 2009 | (ATLANTA) With a combined 40 years of experience, Emory Eye Center neuro-ophthalmologists Nancy J. Newman and Valérie Biousse have collaborated to write Neuro-Ophthalmology Illustrated (Thieme Verlag), a book that they hope will de-mystify the perceived complexity of neuro-ophthalmology, according to the authors. While the book is aimed at medical students, residents, and practicing ophthalmologists and neurologists, it should also be a valuable resource for neurosurgeons, neuroradiologists, and otolaryngologists who deal with patients having disorders of vision and the brain.

  • Emory Eye Center Participates in Nationwide Study Showing that Older Corneas are Suitable for Transplantation Results Could Expand Donor Pool Significantly
    ATLANTA- Corneal transplants using tissue from older donors have similar rates of survival to those using tissue from younger donors reports a nationwide study recently concluded at Emory Eye Center and 79 other sites. The five-year transplant success rate for recipients was the same—86 percent—for transplants performed across the nation with corneas from donors ages 12 to 65 years and from donors ages 66 to 75.
    April 1, 2008

  • Emory Eye Center First U.S. Site to Conduct Keratoconus and Ectasia Trials
    (ATLANTA) Emory Eye Center will be the first U.S. site to conduct an innovative clinical study on patients with keratoconus, a bulging or steepening of the cornea that can lead to, in some cases, scarring of the cornea, or corneal ectasia, a similar condition that can occur after refractive surgery. The new treatment, a minimally invasive, quick procedure, involves riboflavin eye drops—applied to the patient’s cornea and activated by an ultraviolet light. In European studies, the treatment has been shown to increase the amount of collagen cross-linking in the cornea, thereby strengthening it. Cross-linking refers to the natural collagen “anchors” in the corneal tissue. A stronger cornea will not tend to steepen in the way that a diseased one will.
    January 7, 2008

  • Emory Eye Center Among First to Offer New Multi-focal IOL For Cataract Patients Freedom from Glasses a Plus
    (ATLANTA) Emory Eye Center is now offering a newly FDA-approved intraocular lens (IOL) for cataract patients. The lens provides them with a new option for post-surgery vision correction-that of freedom from glasses. The lens provides near, intermediate and far vision capabilities.
    July 21, 2005

  • Emory Laser Vision first in Georgia to offer laser vision correction with PerfectPulse Technology
    A new custom refractive laser, shown to improve quality of vision with regard to daytime and night driving glare, is available for the first time in Georgia, at Emory Laser Vision. The European-designed ALLEGRETTO WAVE excimer laser system with PerfectPulse Technology was the first new platform to be approved by the Food and Drug Administration (FDA) in five years. It is also the only laser system that has received concurrent approvals for nearsightedness and farsightedness with astigmatism and clearance for the widest treatment range ever initially granted to a new laser.
    October 19, 2004

  • Emory Eye Center the site of study to determine best treatment for babies with cataract
    Emory Eye Center will be the lead center among other eye institutes across the country to study what treatment for infants born with a cataract in one eye is the better to attain corrected vision once that cataract is removed: 1) using a contact lens or 2) surgically placing a plastic lens (intra-ocular lens [IOL]) in the baby's eye following removal of the cataract. The Infant Aphakia Treatment Study (IATS) will study infants from age four weeks to seven months.
    October 5, 2004

  • Emory Eye Center physician named one of six "Health Care Heroes" by Atlanta Business Chronicle
    Doyle Stulting, MD, PhD, director of the Cornea Service at Emory Eye Center and medical director of the newly opened Emory Laser Vision, won the prestigious "Health Care Hero" award presented by the Atlanta Business Chronicle at their annual Health Care Heroes Awards and Forum event on May 13. The winner in the "Innovations" category, Dr. Stulting was cited for his groundbreaking artificial cornea transplant surgery last year-the first such surgery in the United States.
    May 17, 2004

  • Emory Eye Center suggests passing up those Halloween eyes: Over-the-counter cosmetic contact lenses pose unseen dangers
    As the Halloween weekend comes closer, more and more teens and young adults may be in danger of losing sight or contracting infections related to the use of popular over-the-counter contact lenses. These lenses- sold at hairdressers, flea markets and even gas stations- are decorative and especially popular around the Halloween holiday. Some give wearers the appearance of cat eyes, for example, or have holiday-specific themes on them. But whatever their design, lenses purchased from these sources are dangerous-and illegal in the United States.
    October 20, 2003

  • Emory Eye Center performs first U.S. artificial corneal transplant with promising new device
    Doyle Stulting, MD, PhD, corneal specialist at Emory Eye Center, performed the first artificial corneal transplant in the U.S. last week using a new device developed in Australia by Argus Biomedical. Both Emory Eye Center and the Cincinnati Eye Institute have been chosen as the first U.S. sites to use the new synthetic keratoprosthesis (artificial corneal device). The cornea is the clear window at the front of the eye, providing physical protection to the eye and part of the eye’s focusing power required for sight. When the cornea becomes diseased or scarred, the passage of light is impaired, thereby limiting vision.
    May 12, 2003

  • Emory Eye Center receives grants to continue Corneal transplants in children
    A $118,000 grant from the Carlos and Marguerite Mason Trust will enable the Emory Eye Center to support the care of children who need cornea transplants. This “bridge funding” the Pediatric Corneal Transplant Program at Emory begins January 2002 and will last one year. The grant comes from Wachovia Bank, which administers funding from the trust created by Carlos and Marguerite Mason. Cornea transplants are the most common form of transplant in medicine. Because of the new techniques and drugs that have been developed over the last four decades, this surgery has a very high success rate.
    February 4, 2002

  • Emory researcher reveals effect of Lasik Surgery on Cornea three years following the procedure
    Emory Eye Center researcher Henry Edelhauser, Ph.D. and co-workers have completed a three-year study on Emory University Eye Center patients who underwent a laser in situ keratomileusis (LASIK) procedure, a refractive surgery to correct eyesight. The patients were evaluated to ascertain the long-term effects of such surgery on the corneal endothelium, the cells that line the inside of the cornea. Sometimes referred to as the "window to the world," the cornea is the transparent covering over the eye.
    March 13, 2001

  • New multifocal lens implant available at Emory benefits cataract patients
    Patients who have cataract surgery at the Emory Eye Center now have a new option for improving their view of the world. More than 1.4 million individuals each year have cataract surgery. In most cases, the eye’s cloudy lens — the cataract — is surgically removed and the focusing power of the eye is restored with an artificial lens. “Now for the first time, patients can have their lenses replaced with a multifocal intraocular lens (IOL) that provides clear vision for both close-up and distance viewing,” said George O. Waring III, M.D., a cornea specialist and professor of ophthalmology, Emory University School of Medicine.
    July 1998

  • Facts about Keratoconus
    “Keratoconus is a progressive eye condition that sometimes is difficult to diagnose,” says Michael Ward, FCISA, director of Emory Eye Center’s contact lens service. “Keratoconus usually affects both eyes and requires careful contact lens management.”

Our Emory campus location:

Copyright © Emory Eye Center - All Rights Reserved | Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA